Recent Content
- Myeloma-bone marrow adipocyte axis in tumour survival and treatment response
- [Action required] Your RSS.app Trial has Expired – Mon Jun 21 2021
- Top Myeloma Journal Articles for the Week of June 14, 2021
- Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial
- MM_Hub: CONGRESS|#EHA2021|@ThierryFacon, Lille University Hospital, presented poster on Phase3 IKEMA trial. It was identified that addition of Isatuximab to carfilzomib & dexamethasone improved PFS & quality of response in elderly pts, with a manageable safety profile #mmsm #myeloma
- VincentRK: The 12th Annual International Myeloma Working Group (IMWG) Summit starts next week. ~100 myeloma experts will participate virtually on new treatment guidelines & research projects. @IMFmyeloma @BrianDurieMD Dr. Munshi and Dr. Kumar will be honored. @DanaFarber @MayoClinic
- MM_Hub: CONGRESS|#EHA2021|@nickbolli, Universita Degli Studi di Milano emphasized upon genotyping potential to diagnose MGUS/SMM, to identify progression determinants, to provide better classification& prognostication of MM. More research is needed for clinical translation #mmsm #myeloma
- MM_Hub: CONGRESS|#EHA2021| Paula Rodriguez- Otero, discussed currently cellular therapies for MM and highlighted future treatment possibilities #mmsm #myeloma @ClinicaNavarra
- MM_Hub: CONGRESS|#EHA2021|@IreneGhobrial, @Mohty_EBMT discussed in an interactive session about factors, challenges in selecting therapy, optimization & pt management after 1st relapse in RRMM #mmsm #myeloma
- MM_Hub: CONGRESS|#EHA2021|@JoshuaRichterMD & Fredrik Schjesvold discussed clinical challenges for late stage RRMM pts. Implication of 5 possible treatment options was also debated #mmsm #myeloma